The aim of this study is to determine if duloxetine is associated with differences in
post-operative pain, patient-reported outcome measures, and opioid consumption in patients
undergoing primary total knee arthroplasty compared to patients who do not receive the
medication. If so, duloxetine has the potential to become widely incorporated into the
multi-modal analgesic regimen given to patients following knee replacements.